The broad, long-term objectives of the Biostatistics Core (Core F) are to provide a full spectrum of statistical consulting services for HIV/AIDS-related research ofthe UNC CFAR.
The specific aims i nclude (1) providing a full spectrum of collaborative biostatistical services, (2) serving as a liaison between AIDS researchers and statistical scientists within the UNC CFAR research community and beyond, (3) providing scientific leadership, (4) providing biostatistical training and education to the UNC CFAR research community, and (5) engaging in evaluation and strategic planning to address the changing needs ofthe UNC CFAR. To achieve these aims, members of Core F proactively engage UNC CFAR investigators to identify and deliver services essential for highly productive design, management, analysis and publication ofAIDS research. Core F contributes to the framing of hypotheses, development of study designs, preparation of grant applications, selection of best statistical strategies, and delivery of statistical analyses required for publications. Investigators new to AIDS research receive highest priority. Core F also serves as a nexus between statistical and biomedical scientists in HIV research. Through the Core, clinicians are linked to statistical coinvestigators, while statisticians initiating AIDS-related methods research are connected with clinical coinvestigators. Organization as a formal Biostatistics Cpre greatly enhances the efficiency and ability of the Core to connect communities of scientists and to provide mentoring and training in statistics to AIDS researchers. Strong institutional support from the Department of Biostatistics allows Core F to take full advantage of existing infrastructure, resources and contacts with faculty renowned for their expertise in specialized fields of statistics. The Core proactively seeks Biostatistics faculty and students interested in participating as new members of Core F.
Consistent with the mission ofthe NIH CFAR Program, the Biostatistics Core delivers essential biostatistical support and expertise to HIV/AIDS investigators ofthe UNC CFAR. These collaborative contributions ensure investigators make measurements, inferences, and predictions that are accurate, precise, and relevant to their particular research goals.
|Chung, Neo Christopher; Bolton-Moore, Carolyn; Chilengi, Roma et al. (2017) Patient engagement in HIV care and treatment in Zambia, 2004-2014. Trop Med Int Health 22:332-339|
|Masa, Rainier; Chowa, Gina; Nyirenda, Victor (2017) Prevalence and Predictors of Food Insecurity among People Living with HIV Enrolled in Antiretroviral Therapy and Livelihood Programs in Two Rural Zambian Hospitals. Ecol Food Nutr 56:256-276|
|Dumond, J B; Collins, J W; Cottrell, M L et al. (2017) p16INK4a , a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected Subjects. CPT Pharmacometrics Syst Pharmacol 6:120-127|
|Dubrow, Robert; Qin, Li; Lin, Haiqun et al. (2017) Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr 75:382-390|
|Noorhasan, Marisela; Drozd, Daniel R; Grunfeld, Carl et al. (2017) Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV. AIDS Res Hum Retroviruses :|
|Meade, Christina S; Hobkirk, Andrea L; Towe, Sheri L et al. (2017) Cocaine dependence modulates the effect of HIV infection on brain activation during intertemporal decision making. Drug Alcohol Depend 178:443-451|
|Tang, Weiming; Huang, Shujie; Chen, Lei et al. (2017) Late Neurosyphilis and Tertiary Syphilis in Guangdong Province, China: Results from a Cross-sectional Study. Sci Rep 7:45339|
|Nixon, Daniel E; Bosch, Ronald J; Chan, Ellen S et al. (2017) Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A52 J Clin Lipidol 11:61-69|
|Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N et al. (2017) HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr 76:319-329|
|Rossouw, Theresa; Tucker, Joseph D; van Zyl, Gert U et al. (2017) Barriers to HIV remission research in low- and middle-income countries. J Int AIDS Soc 20:21521|
Showing the most recent 10 out of 1520 publications